Evidence map›Paper›PMID 9625772›Full record

ArticleThe Journal of experimental medicine1998

Developmentally regulated extinction of Ly-49 receptor expression permits maturation and selection of NK1.1+ T cells.

H Robson MacDonald, R K Lees, W Held

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 62 citations in OpenAlex.

  1. Functional Characterization of Ly49Frontiers in immunology · 2020
    Article
  2. Article
  3. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

H Robson MacDonaldLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland. hughrobson.macdonald@isrec.unil.ch
R K Lees
W Held
University of Lausanne · CHLudwig Cancer Research · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clonally distributed inhibitory receptors negatively regulate natural killer (NK) cell function via specific interactions with allelic forms of major histocompatibility complex (MHC) class I molecules. In the mouse, the Ly-49 family of inhibitory receptors is found not only on NK cells but also on a minor (NK1.1+) T cell subset. Using Ly-49 transgenic mice, we show here that the development of NK1.1+ T cells, in contrast to NK or conventional T cells, is impaired when their Ly-49 receptors engage self-MHC class I molecules. Impaired NK1.1+ T cell development in transgenic mice is associated with a failure to select the appropriate CD1-reactive T cell receptor repertoire. In normal mice, NK1.1+ T cell maturation is accompanied by extinction of Ly-49 receptor expression. Collectively, our data imply that developmentally regulated extinction of inhibitory MHC-specific receptors is required for normal NK1.1+ T cell maturation and selection.

Indexed as

Antigens, LyProtein BiosynthesisProteinsAnimalsAntigensAntigens, SurfaceCell DifferentiationFlow CytometryKiller Cells, NaturalLectins, C-TypeLiverMembrane GlycoproteinsMiceMice, TransgenicNK Cell Lectin-Like Receptor Subfamily BReceptors, Antigen, T-CellAntigensAntigens, LyAntigens, SurfaceKlrb1c protein, mouseLectins, C-TypeMembrane GlycoproteinsNK Cell Lectin-Like Receptor Subfamily BProteinsReceptors, Antigen, T-CellReceptors, ImmunologicReceptors, NK Cell Lectin-Like

Identifiers

PMID9625772
PMCPMC2212363
OpenAlexW2168928173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.